Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

Similar articles for PubMed (Select 22888603)

1.
2.

Consistency as an alternative to potency testing.

Duchow K.

Dev Biol (Basel). 2012;134:119-22. No abstract available.

PMID:
22888604
3.

The consistency approach for quality control of vaccines - a strategy to improve quality control and implement 3Rs.

De Mattia F, Chapsal JM, Descamps J, Halder M, Jarrett N, Kross I, Mortiaux F, Ponsar C, Redhead K, McKelvie J, Hendriksen C.

Biologicals. 2011 Jan;39(1):59-65. doi: 10.1016/j.biologicals.2010.12.001. Epub 2011 Jan 31.

PMID:
21277791
4.
5.

Potency testing of veterinary vaccines: the way from in vivo to in vitro.

Romberg J, Lang S, Balks E, Kamphuis E, Duchow K, Loos D, Rau H, Motitschke A, Jungbäck C.

Biologicals. 2012 Jan;40(1):100-6. doi: 10.1016/j.biologicals.2011.10.004. Epub 2011 Nov 9.

PMID:
22075457
6.

The validation of potency tests: hurdles identified by EMA/CVMP/IWP.

Woodland R.

Dev Biol (Basel). 2012;134:69-73.

PMID:
22888597
7.

Potency testing of veterinary vaccines for animals: the way from in vivo to in vitro. Workshop summary.

[No authors listed]

Dev Biol (Basel). 2012;134:149-52. No abstract available.

PMID:
22888608
8.

Reduction of animal use in human vaccine quality control: opportunities and problems.

Metz B, Hendriksen CF, Jiskoot W, Kersten GF.

Vaccine. 2002 Jun 7;20(19-20):2411-30. Review.

PMID:
12057596
11.

Reducing the use of the target animal batch safety test for veterinary vaccines.

Roberts B, Lucken RN.

Dev Biol Stand. 1996;86:97-102.

PMID:
8785997
12.

Potential application of the consistency approach for vaccine potency testing.

Arciniega J, Sirota LA.

Dev Biol (Basel). 2012;134:135-9.

PMID:
22888606
14.

Towards in vitro potency testing of inactivated erysipelas vaccines.

Balks E, Wolf C, Loessner H, Werner E.

Dev Biol (Basel). 2012;134:37-44.

PMID:
22888593
16.

Three Rs Approaches in the Production and Quality Control of Fish Vaccines.

Midtlyng PJ, Hendriksen C, Balks E, Bruckner L, Elsken L, Evensen O, Fyrand K, Guy A, Halder M, Hawkins P, Kisen G, Romstad AB, Salonius K, Smith P, Sneddon LU.

Biologicals. 2011 Mar;39(2):117-28. doi: 10.1016/j.biologicals.2011.02.001. Epub 2011 Mar 2.

PMID:
21371907
17.

Good manufacturing practice for immunological veterinary medicinal products.

Todd JI.

Rev Sci Tech. 2007 Apr;26(1):135-45. Review.

PMID:
17633298
18.

Replacement, reduction and refinement alternatives to animal use in vaccine potency measurement.

Hendriksen CF.

Expert Rev Vaccines. 2009 Mar;8(3):313-22. doi: 10.1586/14760584.8.3.313. Review.

PMID:
19249973
19.

Potency testing of veterinary rabies vaccines: replacement of challenge by in vitro testing: considerations for development of alternative assays.

Lewis CE, Fry AM, Hermann JR, Siev D, Dusek DM, Gatewood DM.

Dev Biol (Basel). 2012;134:29-33.

PMID:
22888592
20.

Human adenovirus-vectored foot-and-mouth disease vaccines: establishment of a vaccine product profile through in vitro testing.

Brake DA, McIlhaney M, Miller T, Christianson K, Keene A, Lohnas G, Purcell C, Neilan J, Schutta C, Barrera J, Burrage T, Brough DE, Butman BT.

Dev Biol (Basel). 2012;134:123-33.

PMID:
22888605
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk